跳至主要内容
临床试验/CTRI/2018/07/014963
CTRI/2018/07/014963尚未招募不适用

A single centre retrospective study of survival, prognostic factors and treatment in colorectal cancer patients at tertiary care centre in India.

max healthcare pvt ltd1 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2018年7月19日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
95
试验地点
1
主要终点
1.Estimation of overall survival (OS) rate and median overall survival of colorectal cancer treated patients

研究概览

简要总结

There is limited number of studies regarding theprevalence, awareness in Indian subjects. So our study will add to theavailable epidemiological data and also analyse the factors impacting thesurvival of patents in Indian colorectal patients.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Histologically proven colorectal carcinoma.

排除标准

  • Patient clinical data not available.

结局指标

主要结局

1.Estimation of overall survival (OS) rate and median overall survival of colorectal cancer treated patients

时间窗: 1 month

次要结局

  • 1.Estimation of all treatment response in colorectal cancer patients.(2.Estimation of survival in different prognostic factor)

研究者

发起方
max healthcare pvt ltd
申办方类型
Private hospital/clinic

研究点 (1)

Loading locations...

相似试验